Clinical and Molecular Hepatology
译名:临床与分子肝脏病学
>15
2026
影响因子区间
—
平台估算
39%
2025
中国作者发文占比
1700 USD
收费
期刊简介:Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English. Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.
【译文】临床和分子肝病学(Clin Mol Hepatol),是一本国际性的、同行评审的、开放获取的期刊,每季度用英语出版。临床和分子肝病学旨在分享关于肝胆疾病的高级和最新知识、趋势和认识,为临床医生、转化研究人员和基础科学家提供一个广泛的学术论坛,以活跃的辩论和讨论,并通过多学科方法提高公共卫生,特别是在B病毒感染和肝细胞癌高发的资源有限亚太地区,以及东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 1区 | 暂无 |
| 影响因子区间 | >15 | 暂无 |